This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 21/11/2698    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ponugoti, B. Articles by Kemper, J. K. Search for Related Content PubMed PubMed Citation Articles by Ponugoti, B. Articles by Kemper, J. K.

Functional Interaction of Hepatic Nuclear Factor-4 and Peroxisome Proliferator-Activated Receptor- Coactivator 1 in CYP7A1 Regulation Is Inhibited by a Key Lipogenic Activator, Sterol Regulatory Element-Binding Protein-1c

Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801

Address all correspondence and requests for reprints to: J. Kim Kemper, Department of Molecular and Integrative Physiology, University of Illinois, Urbana, Illinois 61801. E-mail: jongsook{at}uiuc.edu.

Insulin inhibits transcription of cholesterol 7-hydroxylase (Cyp7a1), a key gene in bile acid synthesis, and the hepatic nuclear factor-4 (HNF-4) site in the promoter was identified as a negative insulin response sequence. Using a fasting/feeding protocol in mice and insulin treatment in HepG2 cells, we explored the inhibition mechanisms. Expression of sterol regulatory element-binding protein-1c (SREBP-1c), an insulin-induced lipogenic factor, inversely correlated with Cyp7a1 expression in mouse liver. Interaction of HNF-4 with its coactivator, peroxisome proliferator-activated receptor- coactivator 1 (PGC-1), was observed in livers of fasted mice and was reduced after feeding. Conversely, HNF-4 interaction with SREBP-1c was increased after feeding. In vitro studies suggested that SREBP-1c competed with PGC-1 for direct interaction with the AF2 domain of HNF-4. Reporter assays showed that SREBP-1c, but not of a SREBP-1c mutant lacking the HNF-4 interacting domain, inhibited HNF-4/PGC-1 transactivation of Cyp7a1. SREBP-1c also inhibited PGC-1-coactivation of estrogen receptor, constitutive androstane receptor, pregnane X receptor, and farnesoid X receptor, implying inhibition of HNF-4 by SREBP-1c could extend to other nuclear receptors. In chromatin immunoprecipitation studies, HNF-4 binding to the promoter was not altered, but PGC-1 was dissociated, SREBP-1c and histone deacetylase-2 (HDAC2) were recruited, and acetylation of histone H3 was decreased upon feeding. Adenovirus-mediated expression of a SREBP-1c dominant-negative mutant, which blocks the interaction of SREBP-1c and HNF-4, partially but significantly reversed the inhibition of Cyp7a1 after feeding. Our data show that SREBP-1c functions as a non-DNA-binding inhibitor and mediates, in part, suppression of Cyp7a1 by blocking functional interaction of HNF-4 and PGC-1. This mechanism may be relevant to known repression of many other HNF-4 target genes upon feeding.

NURSA Molecule Pages Link:

Nuclear Receptors:   SHP  |  FXRα  |  PXR  |  CAR  |  HNF4α  |  ERα

Coregulators:   PGC-1  |  SRC-1  |  GRIP1  |  AIB1

Ligands:   Rifampicin  |  GW4064  |  17β-Estradiol  |  TCPOBOP